SCHEMBL17368420

SCHEMBL17368420

CCCC(=O)Nc1ccc(C(=O)OC(C)(C)C)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.58
▸ THRB P10828 1/20 0.56
▸ RAB9A P51151 3/20 0.55
▸ MEN1 O00255 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ MAPT P10636 4/20 0.53
▸ ALDH1A1 P00352 3/20 0.53
▸ HPGD P15428 2/20 0.53
▸ GAA P10253 1/20 0.52
▸ LMNA P02545 3/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ NPC1 O15118 2/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ MTNR1B P49286 1/20 0.50
▸ HTR1A P08908 1/20 0.50
▸ HTR7 P34969 1/20 0.50
▸ CA12 O43570 1/20 0.50
▸ CA1 P00915 1/20 0.50
▸ CA2 P00918 1/20 0.50
▸ CA9 Q16790 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17368421 0.88 RAB9A (0.57) RAB9AMEN1KMT2AMAPTALDH1A1
SCHEMBL14068236 0.84 TP53 (0.62) TP53THRBRAB9AMEN1KMT2A
SCHEMBL11914007 0.84 HTR1A (0.53) RAB9AMEN1KMT2AMAPTALDH1A1
SCHEMBL11913978 0.84 ALDH1A1 (0.56) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL7925092 0.83 MEN1 (0.54) RAB9AMEN1KMT2AMAPTALDH1A1
SCHEMBL21639611 0.83 KMT2A (0.58) RAB9AMEN1KMT2AMAPTALDH1A1
SCHEMBL14116517 0.83 MEN1 (0.54) RAB9AMEN1KMT2AMAPTALDH1A1
SCHEMBL1560956 0.83 HTR1A (0.55) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL23176635 0.82 MAPT (0.61) RAB9AMEN1KMT2AMAPTALDH1A1
SCHEMBL9843022 0.81 GAA (0.76) TP53THRBRAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150376120-A1 ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS Technische Universität Berlin (DE) 2015-12-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376120-A1 ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS MB, ALB, BCAT2 TP53 3997/4885THRB 2222/4885RAB9A 1659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback